Individual Strategies -
Decades of Experience Handling Florida
Personal Injury and Wrongful Death Claims
The U.S. Food and Drug Administration requested that Eisai Inc, the manufacturer of Belviq and Belviq XR also known under the generic name lorcaserin be pulled from the U.S. market as clinical trials conducted in January 2020 showed that patients taking this popular drug for weight loss are likely to develop cancer. The preliminary safety data was concerning and led to a recall in February 2020. The FDA urges patients to stop taking lorcaserin and speak with their healthcare providers about different measures for their weight loss program.
Belviq is classified as a weight loss drug, and one of the first that has been proven to help people keep their weight off without increasing their risk of developing a heart condition. At least that is what the conclusion of a 12,000 patient, five year study conducted by the Japanese manufacturer Eisai Inc determined after the FDA required them to do so to get the drug approved.
The FDa analyzed the results of this study and found that 7.7% of patients in the study taking Belviq were diagnosed with cancer, which is just a tick higher than the 7.1% who received the same cancer diagnosis after taking placebo pills.
The FDA said in its report that a wide range of cancers were diagnosed in patients, but the most reports in patients taking Belviq were pancreatic, colorectal and lung cancer. The FDA says that patients have only seen an increased risk after using the drug for a prolonged period of time. No special screening is recommended at this time for anyone who used Belviq or Lorcaserin for a brief time.
Eisai Inc did voluntarily remove their drug from the U.S. market, but firmly believe that Belviq’ benefits outweigh its risks. This drug was intended for adults with a body mass index of 30 and a BMI of 27 who also have other special conditions for heart risk, including high cholesterol, high blood pressure, or Type 2 diabetes.
The extended-release version of the drug, Belviq XR, has also been removed from the market per the FDA.
The FDA says it is best to dispose of any unused drugs at a drug take back facility. You can find one near you here.
If you cannot find a location near you or get to one, there are other ways to dispose of your unused meds.
You will want to speak with your healthcare provider about possible side effects and what you should be on the lookout for. If you need to report any side effects, you can report them to the FDA here.
If you are an adult who has taken Belviq, Belviq XR, or any form of Lorcaserin for weight loss and then received a cancer diagnosis, you may very well have the right to take legal action against the manufacturer of the dangerous drug. Our Florida Belviq, Belviq XR, Lorcaserin Dangerous Drug Cancer Lawsuit Attorneys at Whittel & Melton can help you understand your rights and how to proceed with your case. We are proud to serve clients and their families throughout the state of Florida, including Brooksville, Spring Hill, Ocala, The Villages, Gainesville, Jacksonville, Tampa, New Port Richey, Dade City, Zephyrhills, Wesley Chapel, Lutz, Leesburg, Hudson, Bushnell, Inverness, Crystal River, St. Petersburg, Bronson, Cedar Key, Tavares, Clermont, Orlando, Osceola, Sarasota, Fort Lauderdale, West Palm Beach, Boca Raton, Miami, and Key West.
We can help you determine if you are eligible to file a claim and what you may be entitled to recover. Every case is different, but you may be eligible for compensation for lost wages, medical bills, loss of earning capacity, pain and suffering, funeral expenses, and other damages as a result of using the dangerous drug. We can analyze the evidence pertaining to your case and help you file a claim.
There are no up front fees to hire us. We only get paid if you do. You will pay us nothing out of your own pocket – we only recover our fees if you receive a settlement or jury award.
To learn more about how we can help you, please call us today at 866-608-5529 or contact us online.